IRIS
MORGESE, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.221
EU - Europa 491
AS - Asia 161
AF - Africa 19
SA - Sud America 1
Totale 1.893
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.221
IT - Italia 127
UA - Ucraina 91
SE - Svezia 82
IE - Irlanda 68
TR - Turchia 47
CN - Cina 45
DE - Germania 45
SG - Singapore 43
DK - Danimarca 30
FI - Finlandia 28
CI - Costa d'Avorio 19
KR - Corea 17
GB - Regno Unito 10
IN - India 8
BE - Belgio 4
AT - Austria 2
FR - Francia 2
JP - Giappone 1
LT - Lituania 1
PE - Perù 1
RU - Federazione Russa 1
Totale 1.893
Salva come PNG Salva come JPEG
Città #
Chandler 186
Jacksonville 114
Ashburn 107
Fairfield 99
Dublin 68
Des Moines 66
New York 64
Wilmington 59
Seattle 53
Woodbridge 48
Boardman 45
Houston 41
Cambridge 33
Ann Arbor 32
Lawrence 25
Princeton 25
Turin 25
San Mateo 24
Centro 21
Abidjan 19
Ancona 18
Singapore 16
Los Angeles 13
Washington 12
Helsinki 11
San Diego 10
Pune 8
Beijing 7
Norwalk 7
Guangzhou 6
Falls Church 5
Brussels 4
Jiaxing 4
Kilburn 3
Montegiorgio 3
Shanghai 3
Wuxi 3
Castelraimondo 2
Chengdu 2
Marche 2
Parma 2
Segrate 2
Vienna 2
Wuhan 2
Zhengzhou 2
Arequipa 1
Bevagna 1
Brandenburg 1
Chiswick 1
Falconara Marittima 1
Fayetteville 1
Foligno 1
London 1
Porto 1
Prescot 1
San Severino Marche 1
Sano 1
Tolentino 1
Trecastelli 1
Zibo 1
Totale 1.318
Salva come PNG Salva come JPEG
Nome #
Thymic neoplasms: an update on the use of chemotherapy and new targeted therapies. A literature review. 112
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy 100
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis 88
Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach 87
Electrolyte disorders in cancer patients: a systematic review 85
Gender differences and outcome of melanoma patients 83
Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma 81
Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy-A literature review 80
Hyponatremia in cancer patients: Time for a new approach 79
Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy 79
Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma 77
Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. 76
Gender Differences and Outcomes in Melanoma Patients 76
Risk of hyponatraemia in cancer patients treated with targeted therapies: A systematic review and meta-analysis of clinical trials 72
Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex 71
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy 70
Locally advanced rectal cancer: the importance of a multidisciplinary approach. 69
Medical treatment for gastro-entero-pancreatic neuroendocrine tumours 69
New findings on thymic epithelial tumors: Something is changing 68
Systemic treatment for lung carcinoids: from bench to bedside 68
IMPACT OF VEGF, VEGFR, PDGFR, HIF AND ERCC1 GENE POLYMORPHISMS ON THYMIC MALIGNANCIES OUTCOME 67
High CTLA-4 expression correlates with poor prognosis in thymoma patients 67
Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients 60
Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer 60
Treatment of advanced small cell lung cancer 49
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type 46
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study 16
Comparison Between First Line Target Therapy and Immunotherapy in Different Prognostic Categories of BRAF Mutant Metastatic Melanoma Patients: An Italian Melanoma Intergroup Study 5
Totale 1.960
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.668
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.668
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020145 1 0 17 4 17 0 18 1 20 13 12 42
2020/2021434 27 44 69 2 60 24 24 38 43 41 36 26
2021/2022188 13 29 10 5 4 22 7 9 19 23 16 31
2022/2023556 30 70 33 50 24 116 0 25 113 4 80 11
2023/2024344 43 7 23 21 44 113 4 22 3 16 3 45
2024/202563 63 0 0 0 0 0 0 0 0 0 0 0
Totale 1.960